Recently, another interesting biomarker in cholangiocarcinoma is PSMA has been found for the first time in the tumor-associated neovasculature of most cholangiocarcinoma cases (79.3%) in a large sample set. This evidence concerns the gene FOLH1 and cholangiocarcinoma.